Prediction of radiation-induced malfunction for cardiac implantable electronic devices (CIEDs).
Monte Carlo calculation
cardiac implantable electronic devices
neutron
soft error
Journal
Medical physics
ISSN: 2473-4209
Titre abrégé: Med Phys
Pays: United States
ID NLM: 0425746
Informations de publication
Date de publication:
Apr 2020
Apr 2020
Historique:
received:
05
07
2019
revised:
22
01
2019
accepted:
25
01
2020
pubmed:
1
2
2020
medline:
26
1
2021
entrez:
1
2
2020
Statut:
ppublish
Résumé
Cardiac implantable electronic devices (CIEDs) were believed to possess a tolerance dose to malfunction during radiotherapy. Although recent studies have qualitatively suggested neutrons as a cause of malfunction, numerical understanding has not been reached. The purpose of this work is to quantitatively clarify the contribution of secondary neutrons from out-of-field irradiation to the malfunction of CIEDs as well as to deduce the frequency of malfunctions until completion of prostate cancer treatment as a typical case. Measured data were gathered from the literature and were re-analyzed. Firstly, linear relationship for a number of malfunctions to the neutron dose was suggested by theoretical consideration. Secondly, the accumulated number of malfunctions of CIEDs gathered from the literature was compared with the prescribed dose, scattered photon dose, and secondary neutron dose for analysis of their correlation. Thirdly, the number of malfunctions during a course of prostate treatment with high-energy X-ray, passive proton, and passive carbon-ion beams was calculated while assuming the same response to malfunctions, where X-rays consisted of 6-MV, 10-MV, 15-MV, and 18-MV beams. Monte Carlo simulation assuming simple geometry was performed for the distribution of neutron dose from X-ray beams, where normalization factors were applied to the distribution so as to reproduce the empirical values. Linearity between risk and neutron dose was clearly found from the measured data, as suggested by theoretical consideration. The predicted number of malfunctions until treatment completion was 0, 0.02 ± 0.01, 0.30 ± 0.08, 0.65 ± 0.17, 0.88 ± 0.50, and 0.14 ± 0.04 when 6-MV, 10-MV, 15-MV, 18-MV, passive proton, and passive carbon-ion beams, respectively, were employed, where the single model response to a malfunction of 8.6 ± 2.1 Sv Numerical understanding of the malfunction of CIEDs has been attained for the first time. It has been clarified that neutron dose is a good scale for the risk of CIEDs in radiotherapy. Prediction of the frequency of malfunction as well as discussion of the risk to CIEDs in radiotherapy among the multiple modalities have become possible. Because the present study quantitatively clarifies the neutron contribution to malfunction, revision of clinical guidelines is suggested.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1489-1498Subventions
Organisme : JSPS KAKENHI
ID : JP18K15647
Informations de copyright
© 2020 American Association of Physicists in Medicine.
Références
Marbach JR, Sontag MR, Van Dyk J, Wolbarst AB. Management of radiation oncology patients with implanted cardiac pacemakers: report of AAPM Task Group No. 34. American Association of Physicists in Medicine. Med Phys. 1994;21:85-90.
Raitt MH, Stelzer KJ, Laramore GE, et al. Runaway pacemaker during high-energy neutron radiation therapy. Chest. 1994;106:955-957.
Hoecht S, Rosenthal P, Sancar D, et al. Implantable cardiac defibrillators may be damaged by radiation therapy. J Clin Oncol. 2002;20:2212-2213.
Hurkmans CW, Scheepers E, Springorum BG, et al. Influence of radiotherapy on the latest generation of implantable cardioverter defibrillators. Int J Radiat Oncol Biol Phys. 2005;63:282-289.
Lau DH, Wilson L, Stiles MK, et al. Defibrillator reset by radiotherapy. Int J Cardiol. 2008;130:e37-e38.
Zweng A, Schuster R, Hawlicek R, et al. Life-threatening pacemaker dysfunction associated with therapeutic radiation: a case report. Angiology. 2009;60:509-512.
Dasgupta T, Barani IJ, Roach M 3rd. Successful radiation treatment of anaplastic thyroid carcinoma metastatic to the right cardiac atrium and ventricle in a pacemaker-dependent patient. Radiat Oncol. 2011;6:16.
Makkar A, Prisciandaro J, Agarwal S, et al. Effect of radiation therapy on permanent pacemaker and implantable cardioverter-defibrillator function. Heart Rhythm. 2012;9:1964-1968.
Elders J, Kunze-Busch M, Smeenk RJ, et al. High incidence of implantable cardioverter defibrillator malfunctions during radiation therapy: neutrons as a probable cause of soft errors. Europace. 2013;15:60-65.
Hurkmans CW, Scheepers E, Springorum BG, et al. Influence of radiotherapy on the latest generation of pacemakers. Radiother Oncol. 2005;76:93-98.
Kapa S, Fong L, Blackwell CR, et al. Effects of scatter radiation on ICD and CRT function. Pacing Clin Electrophysiol. 2008;31:727-732.
Wadasadawala T, Pandey A, Agarwal JP, et al. Radiation therapy with implanted cardiac pacemaker devices: a clinical and dosimetric analysis of patients and proposed precautions. Clin Oncol. 2011;23:79-85.
Kesek M, Nyholm T, Asklund T. Radiotherapy and pacemaker: 80 Gy to target close to the device may be feasible. Europace. 2012;14:1595.
Ahmed I, Zou W, Jabbour SK. High dose radiotherapy to automated implantable cardioverter-defibrillator: a case report and review of the literature. Case Rep Oncol Med. 2014;2014:989857.
Augustynek M, Korpas D, Penhaker M, et al. Monitoring of CRT-D devices during radiation therapy in vitro. Biomed Eng Online. 2016;15:29.
Grant JD, Jensen GL, Tang C, et al. Radiotherapy-induced malfunction in contemporary cardiovascular implantable electronic devices. JAMA Oncol. 2015;1:624-632.
Gelblum DY, Amols H. Implanted cardiac defibrillator care in radiation oncology patient population. Int J Radiat Oncol Biol Phys. 2009;73:1525-1531.
Soejima T, Yoden E, Nishimura Y, et al. Radiation therapy in patients with implanted cardiac pacemakers and implantable cardioverter defibrillators: a prospective survey in Japan. J Radiat Res. 2011;52:516-521.
Hashii H, Hashimoto T, Okawa A, et al. Comparison of the effects of high-energy photon beam irradiation (10 and 18 MV) on 2 types of implantable cardioverter-defibrillators. Int J Radiat Oncol Bio Phys. 2013;85:840-845.
Zecchin M, Morea G, Severgnini M, et al. Malfunction of cardiac devices after radiotherapy without direct exposure to ionizing radiation: mechanisms and experimental data. Europace. 2016;18:288-293.
Zecchin M, Artico J, Morea G, et al. Radiotherapy and risk of implantable cardioverter-defibrillator malfunctions: experimental data from direct exposure at increasing doses. J Cardiovasc Med. 2018;19:155-160.
Oshiro Y, Sugahara S, Noma M, et al. Proton beam therapy interference with implanted cardiac pacemakers. Int J Radiat Oncol Bio Phys. 2008;72:723-727.
Hashimoto T, Isobe T, Hashii H, et al. Influence of secondary neutrons induced by proton radiotherapy for cancer patients with implantable cardioverter defibrillators. Radiat Oncol. 2012;7:10.
Gomez DR, Poenisch F, Pinnix CC, et al. Malfunctions of implantable cardiac devices in patients receiving proton beam therapy: incidence and predictors. Int J Radiat Oncol Bio Phys. 2013;87:570-575.
Ezzati AO, Studenski MT. Neutron damage induced in cardiovascular implantable electronic devices from a clinical 18 MV photon beam: a Monte Carlo study. Med Phys. 2017;44:5660-5666.
Tsekos A, Momm F, Brunner M, et al. The cardiac pacemaker patient-might the pacer be directly irradiated? Acta Oncol. 2000;39:881-883.
Frantz S, Wagner J, Langenfeld H. [Radiation-induced pacemaker malfunction]. Z Kardiol. 2003;92:415-417.
John J, Kaye GC. Shock coil failure secondary to external irradiation in a patient with implantable cardioverter defibrillator. Pacing Clin Electrophysiol. 2004;27:690-691.
Thomas D, Becker R, Katus HA, et al. Radiation therapy-induced electrical reset of an implantable cardioverter defibrillator device located outside the irradiation field. J Electrocardiol. 2004;37:73-74.
Nemec J. Runaway implantable defibrillator-a rare complication of radiation therapy. Pacing Clin Electrophysiol. 2007;30:16-18.
DiBiase SJ, Eagen J, Dufendach C. The Influence of Intensity Modulated Radiation Therapy (IMRT) on Cardiac Devices in Patients Undergoing Treatment for Prostate Cancer. 2011;81:S212-213.
Gossman MS, Wilkinson JD, Mallick A. Treatment approach, delivery, and follow-up evaluation for cardiac rhythm disease management patients receiving radiation therapy: retrospective physician surveys including chart reviews at numerous centers. Med Dosim. 2014;39:320-324.
Brambatti M, Mathew R, Strang B, et al. Management of patients with implantable cardioverter-defibrillators and pace-makers who require radiation therapy. Heart Rhythm. 2015;12:2148-2154.
Zaremba T, Jakobsen AR, Sogaard M, et al. Risk of device malfunction in cancer patients with implantable cardiac device undergoing radiotherapy: a population-based cohort study. Pacing Clin Electrophysiol. 2015;38:345-356.
Ueyama T, Arimura T, Ogino T, et al. Pacemaker malfunction associated with proton beam therapy: a report of two cases and review of literature-does field-to-generator distance matter? Oxf Med Case Reports. 2016;8:190-194.
Bagur R, Chamula M, Brouillard E, et al. Radiotherapy-induced cardiac implantable electronic device dysfunction in patients with cancer. Am J Cardiol. 2017;119:284-289.
Riva G, Alessandro O, Spoto R, et al. Radiotherapy in patients with cardiac implantable electronic devices: clinical and dosimetric aspects. Med Oncol. 2018;35:73.
Yeung C, Hazim B, Campbell D, et al. Radiotherapy for patients with cardiovascular implantable electronic devices: an 11-year experience. J Interv Card Electrophysiol. 2019;55:333-341.
Baumann RC, Smith EB. Neutron-induced boron fission as a major source of soft errors in deep submicron SRAM devices. 2000 IEEE International Reliability Physics Symposium Proceedings. 38th Annual (Cat. No.00CH37059). 2000: 103-107.
Firestone RB. Table of Isotopes 8th edn. New York, NY: John Wiley & Sons; 1996.
Mouton J, Haug R, Bridier A, et al. Influence of high-energy photon beam irradiation on pacemaker operation. Phys Med Biol. 2002;47:2879-2893.
Uiterwaal GJ, Springorum BGF, Scheepers E, et al. Interference detection in implantable defibrillators induced by therapeutic radiation therapy. Neth Heart J. 2006;14:330-334.
Zaremba T, Jakobsen AR, Thogersen AM, et al. The effect of radiotherapy beam energy on modern cardiac devices: an in vitro study. Europace. 2014;16:612-616.
Mollerus M, Naslund L, Lipinski M, et al. Radiation tolerance of contemporary implantable cardioverter-defibrillators. J Interv Card Electrophysiol. 2014;39:171-175.
Last A. Radiotherapy in patients with cardiac pacemakers. Br J Radiol. 1998;71:4-10.
Kry SF, Bednarz B, Howell RM, et al. AAPM TG 158: Measurement and calculation of doses outside the treated volume from external-beam radiation therapy. Med Phys. 2017;44:e391-e429.
ICRP. Conversion Coefficients for Radiological Protection Quantities for External Radiation Exposures. ICRP Publication 116, Ann. ICRP. 2010; 40.
Shibata K, Iwamoto O, Nakagawa T, et al. JENDL-4.0: a new library for nuclear science and engineering. J Nucl Sci Technol. 2011;48:1-30.
Makishima H, Ishikawa H, Tanaka K, et al. A retrospective study of late adverse events in proton beam therapy for prostate cancer. Mol Clin Oncol. 2017;7:547-552.
Maruyama K, Tsujii H, Nomiya T, et al. Five-year quality of life assessment after carbon ion radiotherapy for prostate cancer. J Radiat Res. 2017;58:260-266.
Sato T, Niita K, Matsuda N, et al. Particle and heavy ion transport code system PHITS, version 2.52. J Nucl Sci Technol. 2013;50:913-923.
Kase KR, Mao XS, Nelson WR. Neutron fluence and energy spectra around the varian clinac 2100C/2300C Medical accelerator. Health Phys. 1998;74:38-47.
Howell RM, Ferenci MS, Hertel NE. Investigation of secondary neutron dose for 18 MV dynamic MLC IMRT delivery. Med Phys. 2005;32:786-793.
Constantin M, Perl J, LoSasso T, et al. Modeling the truebeam linac using a CAD to Geant4 geometry implementation: dose and IAEA-compliant phase space calculations. Med Phys. 2011;38:4018-4024.
Mao XS, Kase KR, Liu JC. Neutron sources in the Varian Clinac 2100C/2300C medical accelerator calculated by the EGS4 code. Health Phys.1997;72:524-529.
Karimi AH, Brkić H, Shahbazi-Gahrouei D, et al. Essential considerations for accurate evaluation of photoneutron contamination in Radiotherapy. Appl Radiat Isot. 2019;145:24-31.
Kry SF, Salehpour M, Followill DS, et al. Out-of-field photon and neutron dose equivalents from step-and-shoot intensitymodulated radiation therapy. Int J Radiat Oncol Bio Phys. 2000;62:1204-1261.
Hauri P, Schneider U. Whole-body dose equivalent including neutrons is similar for 6 MV and 15 MV IMRT, VMAT, and 3D conformal radiotherapy. J Appl Clin Med Phys. 2019;20:56-70.
Yonai S, Matsufuji N, Kanai T, et al. Measurement of neutron ambient dose equivalent in passive carbon-ion and proton radiotherapies. Med Phys. 2008;35:4782-4792.
Yonai S, Matsufuji N, Kanai T. Monte Carlo study on secondary neutrons in passive carbon-ion radiotherapy: identification of the main source and reduction in the secondary neutron dose. Med Phys. 2009;36:4830-4839.
Schneider U, Agosteo S, Pedroni E, et al. Secondary neutron dose during proton therapy using spot scanning. Int J Radiat Oncol Biol Phys. 2002;53:244-251.
Wang X, Poenisch F, Sahoo N, et al. Spot scanning proton therapy minimizes neutron dose in the setting of radiation therapy administered during pregnancy. J Appl Clin Med Phys. 2016;17:366-376.
Yonai S, Matsufuji N, Akahane K. Monte Carlo study of out-of-field exposure in carbon-ion radiotherapy with a passive beam: organ doses in prostate cancer treatment. Phys Med. 2018;51:48-55.
Gould PA, Krahn AD, Canadian Heart Rhythm Society Working Group on Device Advisories. Complications associated with implantable cardioverter-defibrillator replacement in response to device advisories. JAMA. 2006;295:1907-1911.
Sato T, Yasuda H, Niita K, et al. Development of PARMA: PHITS-based analytical radiation model in the atmosphere. Radiat Res. 2008;170:244-259.